Tuesday, March 08, 2005
Journal Club, Monday March 09, 2005
Dr. Shriner has asked us to look at two articles for the next Journal Club which will be on Wednesday March 09, 2005. The articles have already been placed in your mailboxes. If you can't find one, click on the link above to get to the articles.
Cost-Effectiveness of Screening for HIV
in the Era of Highly Active Antiretroviral Therapy
Gillian D. Sanders, Ph.D., Ahmed M. Bayoumi, M.D., Vandana Sundaram, M.P.H.,
S. Pinar Bilir, A.B., Christopher P. Neukermans, A.B., Chara E. Rydzak, B.A.,
Lena R. Douglass, B.S., Laura C. Lazzeroni, Ph.D., Mark Holodniy, M.D.,
and Douglas K. Owens, M.D.
n engl j med 352;6 February 10, 2005
__________________________________________________________
Methicillin-Resistant Staphylococcus aureus:
An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Stan Deresinski, Division of Infectious Disease and Geographic Medicine, Department of Medicine, Stanford University, Stanford, and Santa Clara Valley
Medical Center, San Jose, California
Clinical Infectious Diseases 2005; 40:562–73
Methicillin-resistant Staphylococcus aureus, first identified just over 4 decades ago, has undergone rapid evolutionary changes and epidemiologic expansion. It has spread beyond the confines of health care facilities, emerging anew in the community, where it is rapidly becoming a dominant pathogen. This has led to an important change in the choice of antibiotics in the management of community-acquired infections and has also led to the development of novel antimicrobials.
